更全的杂志信息网

发表论文审稿回复单

发布时间:2024-07-06 06:35:23

发表论文审稿回复单

保持正确的语调,做出回应。

说明

(1)在回复审稿人意见的时候,除了写明修改内容外,还有一些话是必须要写的。这个其实也可以归纳为礼貌用语,大家一般也都会注意到。但是,有些时候还是容易“放飞自我”。实验室的一位师兄,花了很长的时间搞出来一个很有idea的文章。

(2)在回复审稿意见的时候,前面还是客客气气的回复,一读到关于自己核心idea的时候,立马心态就炸了,言辞什么的就有点过激了,最后当然直接被拒了。其实能作为审稿人,一般都是这个领域的专家或者有一定贡献的人,既然能指出你的问题,就说明还是存在不合理的地方,那就认认真真去修改就好了,千万不要太持才傲物。

(3)里很多人都会轻易犯错,尤其是刚发论文的时候,总觉得自己一定要根据审稿人的每一条意见都做出修改。我以自己的亲身经历发誓,这样做只会使你的论文变得支离破碎,可读性变差且言之无物(因为我自己曾改出过这么一篇不忍直视的论文,连我自己都读不下去)。论文上署的是你的名字,你得对所有内容负责。

(4)不妨想想审稿人的审稿动机和职责,他们才不会去想这些审稿意见对你的论文究竟有没有用。如果你不同意某些意见,或者觉得一些意见并不能提升你论文的价值的话,那就把握好回复的分寸,对这些意见予以一定反驳,并且反驳时尽量使用参考文献,使之有理有据。

方法/技巧

1、套话

在回复审稿人意见的时候,除了写明修改内容外,还有一些话是必须要写的。这个其实也可以归纳为礼貌用语,大家一般也都会注意到。但是,有些时候还是容易“放飞自我”。实验室的一位师兄,花了很长的时间搞出来一个很有idea的文章。

在回复审稿意见的时候,前面还是客客气气的回复,一读到关于自己核心idea的时候,立马心态就炸了,言辞什么的就有点过激了,最后当然直接被拒了。其实能作为审稿人,一般都是这个领域的专家或者有一定贡献的人,既然能指出你的问题,就说明还是存在不合理的地方,那就认认真真去修改就好了,千万不要太持才傲物。

比如在回复的时候,前面加上类似“谢谢您的建议,您的所有建议都非常的重要,它们对我今后的科研工作都具有重要的指导意义”;结尾也可以写上“再次谢谢您的建议,希望能够从您那里学到更多的知识。”像这种类似的套话一定要有,时刻保持谦逊。

2、审稿人意见暂时无法实现

第一种是需要你增加实验或改进实验的时候。.原则上尽量满足,实在是不行的,可适当用能说明原理的替代实验满足。当然如果为了论文尽快发表,需要拒绝这样的要求,也不要列出一堆理由来证明这个意见是不好实现的,这样只会让审稿人认为你在逃避。

还有一种就是评价创新性不足。这种几乎是没法改的。原则是需要准确地概括出本文的核心创新点。当然,首先还是要肯定审稿人说的对,他提出的方法或者已经存在的方法也很好,但本文的核心创新点在于balabala,和已经存在的方法不一样。适当的情况下可以比较下优缺点,加一些这方面的总结(觉得自己归纳的不好就别加了,以防能巧成拙)。

注意!对于这类关于创新不足的意见,一定要好好回复。一旦不被认可的话就会评判为文章没创新点,一个没有创新的文章,很难被录用。

3、审稿人意见有问题

坦白说,概率真的很小,但也不是没有。如果真的遇到了,那也不要太过于激动。大家都是有棱有角的年轻人,血气方刚,自己辛辛苦苦做出来的结果被人否定了当然不爽,尤其是对方还是错误的情况下,发几句牢骚就算了,千万别带到邮件里。子还曾经曰过:人非圣贤孰能无过。要注意言辞,一定不能在文中带有“审稿人的意见是错的”这样的句子。

不要对他的意见发表任何的评论,就在那条审稿意见下,列出你的理由和证据就可以了,也不用刻意强调你的观点是正确的。

4、注意回复时间

把握好回复的时间尺度,原则上是不能让编辑觉得你过于草率,不够重视(更不能超过deadline)。要根据具体的修改意见,掌握好修改时间。即使是minor revision,意见比较少的,只需要花一天甚至几小时搞定的,也不要立刻投回去。

至少一周后再投出去,因为在这一周里你还要充足的时间去检查论文里的小毛病,更重要的是,编辑不会觉得你是在敷衍他。如果是major revision,建议至少三周后再投,修改到尽量符合审稿意见上的要求。否则一旦让你重修,将会浪费更多的时间精力。

觉得自己英语不是很好的童鞋,也不要灰心,其实专业词汇就那些。在这里分享一个简单粗暴提升专业英语水平的方法,直接背。其实看似一篇十几页的论文,文字较多的部分也就开头和结尾多一些(理工科一般这样,其它的不清楚,应该差不多)。注意,背诵的对象一定是大牛或高水平的英文文献。

另外,在我大天朝,有需求就会有市场。不过目前市场上提供论文润色服务的机构鱼龙混杂,挑选的时候一定要独具慧眼。千万别找非专业人员润色,很可能失之毫厘谬以千里,学术论文还是很严谨的。

你知道怎么回复审稿意见么

第一,不论审稿人提了什么意见,你在回复的时候一定要说:您的建议,您的所有建议都非常的重要,它们对我的论文写作和科研工作都具有重要的指导意义!第二,如果审稿人提的意见你暂时无法做到(比如,要你增加实验或改进实验等)。那么,为了论文尽快发表,你必须拒绝这样的要求。但是,你不要摆出一大堆理由来证明这个意见是不好实现的。你应该说:“您的建议,它非常的重要,由于您的建议,我发现了我目前工作中的不足之处,我会在以后的工作中按照您的建议提高科研水平,取得更多成绩!”这样说,等于委婉的拒绝了评审意见,又让评审人觉得你很看重他的意见。第三,如果审稿人的意见明显有问题,也不说能说审稿人的意见是错误的,可以他的意见发表任何的评论,只需要列出你的理由和证据就可以了,结尾也不要强调自己的观点是正确的。一句话,就是凭证据说话。第四,如果审稿人的评价比较傲慢,而且有失公平。那么,不用客气,直接写信给编辑,痛批审稿人。(我就遇到过这样的情况,痛批后反而被录用。)第五,在回复信的结尾最好写上再次您的建议,希望能够从您哪里学到更多的知识。这句话最好用黑体,要显眼。

期刊投稿复审已审回

请回答这个到底什么意思?我们的稿件到底有没有戏?有没有可能被录用?

这是三审制,有初审,复审,再复审,已审回证明审稿结果已经出来了,具体是通过与否就看审回结果了,这是一个流程问题。说明你的文章已经通过了前两次审核。希望很大,也得恭喜恭喜。

明显不是退稿的意思。是复审结束,意见已回到编辑部,但是还等待编辑的下一步操作。退稿的话就会标明“建议另投他刊”。

个人认为你投的期刊审稿应该有两步:第一步是初审;第二步是复审。复审就是外审,复审已审回说明外审已给出了审稿的意见,编辑会根据审稿的意见给主编审核。过不了几天就会给出你的结果:是退修、退稿或直接录用,复审已审回是最后的决定阶段,耐心等几天就会有结果。如果你要是急,可以直接给编辑部打电话,问问你的稿件有没有录用,这样更快些!

sci论文发表回复审稿人

你知道怎么回复审稿意见么

1.所有问题必须逐条回答。 2.尽量满足意见中需要补充的实验。3.满足不了的也不要回避,说明不能做的合理理由。 4.审稿人推荐的文献一定要引用,并讨论透彻。 以下是本人对审稿人意见的回复一例,仅供参考。续两点经验:1. 最重要的是逐条回答,即使你答不了,也要老实交代;不要太狡猾,以至于耽误事;2. 绝大部分实验是不要真追加的,除非你受到启发,而想改投另外高档杂志----因为你既然已经写成文章,从逻辑上肯定是一个完整的 “story” 了。以上指国际杂志修稿。国内杂志太多,以至于稿源吃紧,基本没有退稿,所以你怎么修都是接受。我的文章水平都不高,主要是没有明显的创新性,也很苦恼。但是除了开始几篇投在国内杂志外,其他都在国际杂志(也都是SCI)发表。以我了解的情况,我单位其他同志给国内杂志投稿,退稿的极少,只有一次被《某某科学进展》拒绝。究其原因,除了我上面说的,另外可能是我单位写稿子还是比较严肃,导师把关也比较严的缘故。自我感觉总结(不一定对):1)国内杂志审稿极慢(少数除外),但现在也有加快趋势;2)国内杂志编辑人员认真负责的人不多,稿子寄去后,少则几个月,多则一年多没有任何消息;3)国内杂志要求修改的稿子,如果你自己不修,他最后也给你发;4)国外杂志要求补充实验的,我均以解释而过关,原因见少帖)。还因为:很少杂志编辑把你的修改稿再寄给当初审稿人的,除非审稿人特别请求。编辑不一定懂你的东西,他只是看到你认真修改,回答疑问了,也就接受了(当然高档杂志可能不是这样,我的经验只限定一般杂志(影响因子1-5)。欢迎大家批评指正。我常用的回复格式:Dear reviewer:I am very grateful to your comments for the manuscript. According with your advice, we amended the relevant part in manuscript. Some of your questions were answered below.1)2)....引用审稿人推荐的文献的确是很重要的,要想办法和自己的文章有机地结合起来。至于实验大部分都可以不用补做,关键是你要让审稿人明白你的文章的重点是什么,这个实验对你要强调的重点内容不是很必要,或者你现在所用的方法已经可以达到目的就行了。最后要注意,审稿人也会犯错误,不仅仅是笔误也有专业知识上的错误,因为编辑找的审稿人未必是你这个领域的专家。只要自己是正确的就要坚持。在回复中委婉地表达一下你的意见,不过要注意商讨语气哦!我得回复格式是这样的:Dear Professor xx:Thank you very much for your letter dated xxx xx xxxx, and the referees’ reports. Based on your comment and request, we have made extensive modification on the original manuscript. Here, we attached revised manuscript in the formats of both PDF and MS word, for your approval. A document answering every question from the referees was also summarized and enclosed.A revised manuscript with the correction sections red marked was attached as the supplemental material and for easy check/editing purpose.Should you have any questions, please contact us without hesitate.然后再附上Q/A,基本上嘱条回答,写的越多越好(老师语)。结果修改一次就接收了:)我的回复,请老外帮忙修改了Dear Editor:Thank you for your kind letter of “......” on November **, 2005. We revised the manuscript in accordance with the reviewers’ comments, and carefully proof-read the manuscript to minimize typographical, grammatical, and bibliographical errors.Here below is our description on revision according to the reviewers’ comments.Part A (Reviewer 1)1. The reviewer’s comment: ......The authors’ Answer: .....2. The reviewer’s comment: ......The authors’ Answer: ...........Part B (Reviewer 2)1. The reviewer’s comment: ......The authors’ Answer: .....2. The reviewer’s comment: ......The authors’ Answer: ...........Many grammatical or typographical errors have been revised.All the lines and pages indicated above are in the revised manuscript.Thank you and all the reviewers for the kind advice.Sincerely yours,***一个回复的例子(已接收)Major comments: 1. The authors need to strengthen their results by including MMP secretion, and tran-matrigel migration by a positive control progenitor cell population i.e. enriched human CD34 cells obtained from mobilized PBL, since this is a more clinically relevant source of CD34 cells which has also been shown to secrete both MMP-9 and MMP-2 (ref. 11). CD34 enriched cells from steady state peripheral blood which also secrete MMPs are also of interest. 2. In fig 1C please specify which cell line represents MMP-negative cells. This needs to be clarified, as well as a better explanation of the method of the protocol. 3. The ELISA results are represented as "fold increase" compared to control. Instead, we suggest that standards should be used and results should be presented as absolute concentrations and only then can these results be compared to those of the zymography. 4. When discussing the results, the authors should distinguish clearly between spontaneous migration vs chemotactic migration. Furthermore, the high spontaneous migration obtained with cord blood CD34 cells should be compared to mobilized PBL CD34 enriched cells and discussed. 5. The authors claim that the clonogenic assay was performed to determine the optimum concentration for inhibition of MMP activity by phenanthroline and anti MMP-9 mAb, however they should clarify that this assay can only determine the toxicity of the inhibitors and not their optimal inhibitory concentrations.Minor comments: 1. There are many spelling and syntax errors, especially in the results and discussion, which need correction. a. Of special importance, is the percent inhibition of migration, which is described as percent of migration. i.e. pg 7:"Migration of CB CD34 was reduced to 73.3%?" Instead should read "Migration of CB CD34 was reduced by 73.3%?" b. The degree symbol needs to be added to the numbers in Materials and methods. 2. It would be preferable to combine figure 1A and B, in order to confirm the reliability of fig. 1B by a positive control (HT1080).Answer to referee 1 comment: 1. Mobilized peripheral blood is a more clinical source of CD34+ cells, so it is necessary to compare the MMP-9 secretion and trans-migration ability of CB CD34+ cells with that of mobilized PB CD34+ cells. However, we couldn't obtain enough mobilized PB to separate PB CD34+ cells and determine the MMP-9 secretion and migration ability, so we couldn’t complement the study on PB CD34+ cells in this paper. Results obtained by Janowska-Wieczorek et al found that mobilized CD34+ cells in peripheral blood express MMP-9. Furthermore, Domenech’s study showed that MMP-9 secretion is involved in G-CSF induced HPC mobilization. Their conclusions have been added in the discussion. In our present study, our central conclusion from our data is that freshly isolated CD34+ stem/progenitor cells obtained from CB produce MMP-9. 2. MMP-9 negative cell used in fig 1C was Jurkat cell. In zymographic analysis, MMP-9 was not detected in the medium conditioned by Jurkat cell. To exclude that the contaminating cells may play a role in the observed MMP-9 production, we screened the media conditioned by different proportion of CB mononuclear cells with MMP-9 negative cells by zymography. This result may be confusion. Actually, only by detecting the medium conditioned by 2X105 CB mononuclear cells (MNC)/ml (since the purities of CD34+ cell are more than 90%), it could exclude the MNC role. In the revised manuscript, we only detected MMP-9 activity and antigen level in the medium conditioned by 2X105 CB mononuclear cells (MNC)/ml. There is no MMP-9 secretion be detected in the medium conditioned by 2X105 CB MNC/ml. It excluded the possibility that the MMP-9 activity in CB CD34+ cells conditioned medium is due to the contamination by MNC. 3.In this revised paper, we have detected the MMP-9 antigen levels by using commercial specific ELISA kits (R&D System, sensitivity, 0.156ng/ml). Recombinant MMP-9 from R&D System was used as a standard. The results are expressed in the absolute concentration. The absolute concentration result has been added in the paper. As shown in Fig2, MMP-9 levels were detectable in both CB CD34+ cell conditioned medium and BM CD34+ cell conditioned medium. However, MMP-9 level was significantly higher in CB CD34+ cell conditioned medium than in BM CD34+ cell conditioned medium (0.406±0.133ng/ml versus 0.195±0.023ng/ml). Although gelatinolytic activity was not detected in media conditioned by CD34+ cells from BM, sensitivity of ELISA favors the detection of MMP-9 antigen in the BM CD34+. 4. In our study, to establish the direct link between MMP-9 and CB CD34+ cells migration, we only determined the role of MMP-9 in spontaneous migration of CB CD34+ cells, but not in chemotactic migration. Actually, regulation of hematopoietic stem cell migration, homing and anchorage of repopulation cells to the bone marrow involves a complex interplay between adhesion molecules, chemokines, cytokines and proteolytic enzymes. Results obtained by the groups of Voermans reveal that not only the spontaneous migration but also the SDF-1 induced migration of CB CD34+ cells is greatly increased in comparison to CD34+ cells from BM and peripheral blood. 5. CD34+ cells we obtained in each cord blood sample were very limited. It is not enough to screen the inhibitors concentrations to select the optimal inhibitory concentrations. In the blocking experiments, based on the concentrations used by others and the manufacturer's recommendation, we then determined the inhibitors concentrations by excluding the toxicity of the inhibitors in that concentration, which was determined by clonogenic assay.Minor comments:1.The spelling and syntax errors have been checked and corrected.2.Since the results in figure 1A and B were obtained from two separated and parallel experiments, it is not fitness to combine two figures.

期刊投稿回复审稿中

具体问题具体回复,SCI常见的问题优助医学来说一下。编辑们一般会在decisionletter中阐述清楚他们是否认为稿件经修改后足够发表。如果你不确定编辑在信里说的是什么意见,那么不妨回信询问。编辑的工作就是与读者沟通,说明怎样的修改会使文章足够发表(如果他们认为该文章有机会发表到该期刊上),或者为什么作者的文章无法发表(如果他们认为文章没有机会发表)。如果编辑或审稿人认为你的文章当前无法发表,他们其实会指出了你的研究中还有什么需要补充的(或者如果你的文章是理论性的,还有哪些问题你需要阐述得更清楚)。如果你是向实证性期刊投稿,那么只要你增加了足够的数据,便可以再次投稿。当然,当你这样做的时候,最好直接能解决decisionletter和审稿意见中的建议和问题。在大多数情况下,写一封CoverLetter来说明之前decisionletter和审稿意见中提出了哪些问题,并说明新修改的稿件是如何解决这些问题的,会很有帮助(或者如果你没有解决这些问题,阐述清楚为什么这些问题不是阻碍文章发表的原因)。

给范文:Response to commentsDear Editors and Reviewers:Thank you for your letter and for the reviewers’ comments concerning our manuscript entitled xxxxxxxxxxxxxx. Those comments are all valuable and very helpful for revising and improving our paper, as well as the important guiding significance to our researches. We have studied comments carefully and have made correction which we hope meet with approval. The main corrections in the paper and the responds to the reviewer’s comments are as following:Comments:(列举提问题切忌要遗漏任何项)1. ......... Please check and revise.2. .......... Please revise.3. ..........Response:(表示遗憾谢并且详细说明改进程/或解释审稿疑惑要详细题号要应面问题编号)1. We are very sorry for our unclear report in......2. It is our negligence and we are sorry about this. According to comment, related content have been improved. .......3. As the Reviewer's good advice, .......Special thanks to you for your good comments.20xx-xx-xx国外审稿人是义务的,可以根据文章质量和自己的看法自由地提出意见和建议。国外审稿人绝大多数治学严谨,很注重reputation,可以说拿信誉当生 命。当他们接到审稿要求时,如果很忙或不懂你的专业或领域,他们会decline。但只要答应审稿,一般都是尽职尽责的完成审稿任务。因此,当你接到审稿 人的意见时,首先要摆正心态,保持冷静。不要用偏见的心态去断定审稿人有偏见、歧视。做研究的确很辛苦,发表文章也确实很不容易。但审稿人同 样也很辛苦,也很不容易。他们认认真真地阅读你的文章,给你提出中肯的意见,甚至很好的建议。如果还被你措辞强硬的怪罪一阵,换着谁也会生气。要知道,找 理由拒绝一篇文章并不是一件很难的事情。因此,这个时候,你一定要好好的静下心来,好好分析sci论文发表审稿人的意见,找出问题的所在。1.所有问题必须逐条回答;2.尽量满足意见中需要补充的实验;3.满足不了的也不要回避,说明不能做的合理理由;4。对于你不认同的意见,也要委婉有技巧地回答,做到有理有据有节;5. 审稿人推荐的文献一定要引用,并加以讨论。

科研人想要成功发表一篇SCI,往往要经历写作、投稿、等待这一系列漫长的过程,当在收到一篇文章返修意见的时候心里别提有多激动了。 收到返修意见说明文章已经被审稿人初步认可,为了让自己的心血不被浪费,文章能顺利发表,我们要花时间和经历去回复审稿意见,这就要求大家除了具备专业性之外,还要注意回复的语气、格式等细节 本篇文章笔者 手把手教各位科研人如何高情商回复 Reviewers ,很纯的干货,认真读完相信你一定有所收获! 1. 阅读返修意见 首先要认真阅读全部审稿意见,一般每篇文章会有 2-3 个审稿人的意见,每位审稿人的意见数量可能一两条到十几条不等。每位审稿人的意见一般会逐条列出。在阅读退修意见的过程中,我们要清楚目的,首先是弄懂每一条意见,充分 get 审稿人的要求。 其次要对所有意见有一个归纳整理,分清主次。 最后要注意除文章内容之外的一些要求,如文章修回的 deadline,补充完善作者信息等。 2. 制定回复策略 当认真读完审稿人意见之后,建议大家将所有意见复制粘贴到 word 文档,对所列意见逐条分析。根据笔者经验,所有意见可以根据难易程度分为简单、复杂、困难这三种。 下面笔者将以一些既往文章收到过的退修意见为例来向大家说明: 简单的一般是改正错别词、语法,规范格式,补充缩写词全称,提高图片质量,等等。如图 1: 图1 复杂的一般指我们通过查阅文献之后即可用事实依据解答审稿人的疑问,比如为什么选择某个药物、某个实验对象等,因为审稿人有时不一定是你所研究领域的专家,所以我们用事实说话解开审稿人的疑惑也就成功回答了这类问题。如图 2: 图2 困难的一般是指审稿人对文章涉及到的方法、结果、结论等的质疑,这些就需要各位认真斟酌,谨慎回答,切记要有理有据。如图 3: 图3 3. 编辑回复内容 分析过审稿人意见之后,我们就可以着手回复了,下面几条划重点啦: (1)我们注意要对所有的退修意见逐条进行回复 在每条意见下面写上相应回复内容,一般回复的结构为:感谢审稿人的意见+已修改的内容。可以写感谢审稿人善意的提醒/严谨的态度/专业的意见等等,表达出我们虚心学习的态度。 (2)在回复的正文内容的首和尾要分别有一段前言和一段总结 回复的语气一定要诚恳且礼貌,在内容中除了要说明修改的内容之外,还要体现感谢编辑和审稿人对文章的认可以及辛苦的工作。 (3)在回复内容的最后写上「如果有任何问题请随时联系」类似的话 这样既显示了我们认真的态度,也间接表达了我们期盼回复的心情。 (4)如有引用文献回答审稿人问题的,需在回答内容后面附上所参考文献的 DOI 编号,论点+论据会更能使审稿人信服。 下面图 4 为笔者常用的回复审稿人意见的模板,提供给大家参考。 图4 虽然每个人的稿件情况不同,回复信也都是千差万别,但多多少少还是有一定模板性的,尤其是对于第一次遇到这种情况的研究生朋友们,可以先从模板开始熟悉一下此类回复信的大体内容和形式。 模板1:精简版本 下面这个是我自己以前写的一个模板,拿出来分享给大家。 Dear Editor XX and Reviewers, Thanks very much for taking your time to review this manuscript. I really appreciate all your comments and suggestions! Please find my itemized responses in below and my revisions/corrections in the re-submitted files. (这一段基本上是套话) Thanks again! 下面就开始回复文章的审稿意见了,一般首先是回复期刊编辑的整体意见: SUGGESTIONS FROM EDITOR(注意这一段要把编辑原始的建议粘贴在这里,不能只有回应)  Your response to the general comments from the editor 接下来是逐条回应审稿人的建议: COMMENTS TO THE AUTHOR: Reviewer #1: Response to the questions one by one Reviewer #2: Response to the questions one by one 模板2: 完整版本 这个模板是完整版本,保留了很多逐条回答审稿人的常用短语和句式,值得收藏和学习! Dear Editor, Dear reviewers Thank you for your letter dated February 22. We were pleased to know that our work was rated as potentially acceptable for publication in Journal, subject to adequate revision. We thank the reviewers for the time and effort that they have put into reviewing the previous version of the manuscript. Their suggestions have enabled us to improve our work. Based on the instructions provided in your letter, we uploaded the file of the revised manuscript. Accordingly, we have uploaded a copy of the original manuscript with all the changes highlighted by using the track changes mode in MS Word. Appended to this letter is our point-by-point response to the comments raised by the reviewers. The comments are reproduced and our responses are given directly afterward in a different color (red). We would like also to thank you for allowing us to resubmit a revised copy of the manuscript. We hope that the revised manuscript is accepted for publication in the Journal of Mountain Science. Sincerely, XXXXXXX (同样是套话,这个模板写了这么长。。。虽然我不是很喜欢,但是适合拿来逐句学习,为己所用)  Reviewer 1:   Comments to the Author 这个审稿人的意见分为两部分: 第一部分是一般性的评论和修改建议(多为比较大的问题)。 Here are the general comments from the reviewer...  We thank the reviewer for the very interesting comment. In fact… Regarding the suggestion about the methods, we changed this part… Another issue on the methodological section is that...  We are grateful for the suggestion. To be more clear and in accordance with the reviewer concerns, we have added a brief description as follows: “ 接下来是第二部分“小的建议”,也就是需要逐条回复的那种,一般是用词用句的修改。 Minor comments: The title is too long, I suggest shortening.  Modified throughout the text according to the comment (Line 20, page 1).Thank you for the title suggested. The precedent version of the title has been replaced, becoming... Line 25, page 1… Modified throughout the text according to the comment (Line 20, page 1). Line 18, page 2…  We have modified the sentence according to the previous comment (Line 30, page 2).  Line 33, page 3…  Thank you for underlining this deficiency. This section was revised and modified according to the information showed in the work suggested by the reviewer (Line 41, page 3).  Line 59, page 5…  This phrase was modified according to the comment (Line 30, page 5).  Lines 9-24, page 6…  Thank you for the suggestion. We have added the information required as explained above (Lines 6-28, page 6).  Line 11, page 6…  This sentence was rephrased according to the comment (Line 8, page 6).  Line 35, page 13: “exit section”->”outlet” (please check also throughout the text, e.g. at line 54, page 13)  We have modified this expression throughout the text according to the comment. 论文的发表终究还是取决于科研硬实力,以上技巧和经验都只是锦上添花,在论文发表方面助大家一臂之力,让我们的稿件更容易被录用。最后祝每个科研人科研丰收,生活美满!

参考视频

写一篇高水平的工程类英文论文_7_如何回复审稿人+总结+两位牛人的建议

网页链接

发表论文被复审退回

没有别的好办法,按照老师意见进行修改,直到老师满意为止,如果自己能力有限,可花心代价,求教老师或者身边成绩好的同学。

据学术堂了解,论文被退回,分三种情况:一是“文章质量达不到要求”,这种肯定是写作问题,可以找专业的人员修改润色,然后改投;二是专业不符合,学术期刊也分为专业性期刊和综合性期刊,如果你的稿件与期刊专业不一致,也会被退稿,这种直接改投就好了;三是“修改重投”,编辑要求你修改后重投论文,表示他认为你的论文如果能根据建议修改,是有发表的潜力的,关键是一步一步来,系统性地处理审稿人的意见。

根据主编被退回的原因,进行相应修改。一定要仔细研究主编的意思,是不是不符合本杂志的主题。或者选择投其他期刊

通常论文被退,应该是有不合格的地方,应该进行修改,可以详细请教一下指导教师对论文的意见,进行修改完善。

相关百科

服务严谨可靠 7×14小时在线支持 支持宝特邀商家 不满意退款

本站非杂志社官网,上千家国家级期刊、省级期刊、北大核心、南大核心、专业的职称论文发表网站。
职称论文发表、杂志论文发表、期刊征稿、期刊投稿,论文发表指导正规机构。是您首选最可靠,最快速的期刊论文发表网站。
免责声明:本网站部分资源、信息来源于网络,完全免费共享,仅供学习和研究使用,版权和著作权归原作者所有
如有不愿意被转载的情况,请通知我们删除已转载的信息 粤ICP备2023046998号-2